欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DK/H/2111/001
药品名称Olimesta Combi
活性成分
    • hydrochlorothiazide 12.5 mg
    • olmesartan medoxomil 20.0 mg
剂型Film-coated tablet
上市许可持有人KRKA Sverige AB Göta Ark 175 Medborgarplatsen 25 118 72 Stockholm Sweden
参考成员国 - 产品名称Denmark (DK)
Olmesartanmedoxomil/Hydrochlorothiazid Miklich 20/12,5 mg filmovertrukne tabletter
互认成员国 - 产品名称
    • Poland (PL)
    • Latvia (LV)
    • Lithuania (LT)
      Co-Olimestra 20 mg/12,5 mg plėvele dengtos tabletės
    • Estonia (EE)
      CO-OLIMESTRA
    • Bulgaria (BG)
      Co-Olimestra
    • Slovakia (SK)
      Co-Olimestra 20 mg/12,5 mg filmom obalené tablety
    • Slovenia (SI)
      Olmicombi 20 mg/12,5 mg filmsko obložene tablete
许可日期2012/05/02
最近更新日期2024/03/11
药物ATC编码
    • C09DA08 olmesartan medoxomil and diuretics
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase